NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-043-2009-0-PCT-02 Development Of A T-Cell Receptor Targeted To The Human Tyrosinase Tumor Antigen PCT PCT PCT/US10/21909 Expired
NCI E-028-2007-0-JP-09 Novel Insertion Sites In Pox Vectors JP DIV 2010-120319 Expired
NIDCD E-169-2001-0-US-08 Phenylthiocarbamide (PTC) Taste Receptor US CON 12/690,286 8148082 Expired PDF
NICHD E-206-2007-0-US-06 Substrate Reduction Therapy US National Stage 12/666,279 8557844 Issued PDF
NHLBI E-208-2007-0-US-03 Imidazolidinone Compounds, Methods to Inhibit Deubiquination And Methods of Treatment US National Stage 12/669,361 8637560 Issued PDF
NCI E-207-2004-3-US-02 Plasmids And Phages For Homologous Recombination And Methods Of Use US DIV 12/688,764 8541229 Issued PDF
NCI E-151-2008-0-PCT-02 Accurate Prediction Of A Patient's Internal Organ Motion From External Torso Volume Change PCT PCT PCT/US2010/021196 Expired
NCI E-025-2009-0-CA-05 Ratio Based Biomarkers And Methods of Use Thereof CA National Stage 2749601 Issued
NCI E-025-2009-0-JP-23 Ratio Based Biomarkers And Methods of Use Thereof JP DIV 2015-241016 Issued
NCI E-025-2009-0-EP-12 Ratio Based Biomarkers And Methods of Use Thereof EP DIV 13180760.4 Issued
NCI E-025-2009-0-AU-04 Ratio Based Biomarkers And Methods of Use Thereof AU National Stage 2010204741 Issued
NCI E-025-2009-0-JP-08 Ratio Based Biomarkers And Methods of Use Thereof JP National Stage 2011-545543 Issued
NCI E-025-2009-0-IL-07 Ratio Based Biomarkers And Methods of Use Thereof IL National Stage 214046 Issued
NICHD E-183-2005-0-US-03 Methods for Conjugation of Oligosaccharides or Polysaccharides to Protein Carriers through Oxime Linkages via 3-Deoxy-D-Manno-Octulsonic Acid US National Stage 12/309,428 8795680 Issued PDF
NCI E-025-2009-0-GB-15 Ratio Based Biomarkers And Methods of Use Thereof GB EP 10700363.4 Issued
NCI E-025-2009-0-DE-13 Ratio Based Biomarkers And Methods of Use Thereof DE EP 10700363.4 Issued
NCI E-025-2009-0-FR-14 Ratio Based Biomarkers And Methods of Use Thereof FR EP 10700363.4 Issued
NCI E-025-2009-0-EP-06 Ratio Based Biomarkers And Methods of Use Thereof EP National Stage 10700363.4 Issued
NCI E-025-2009-0-PCT-02 Ratio Based Biomarkers And Methods of Use Thereof PCT PCT PCT/US2010/020944 Expired
NCI E-025-2009-0-EP-11 Ratio Based Biomarkers And Methods of Use Thereof EP DIV 13180742.2 Abandoned
NIAID E-076-2010-0-US-01 2-nitro-6(S),7-dihydro-5H-imidazo[2,1-b] [1,3]oxazines And Their Use Against Myocobacterium Tuberculosis US 61/294,634 Abandoned
NCI E-225-2008-0-PCT-02 A Low-Cost, Self-Collection Device ("SELF") For Detection Of Human Papillomavirus(HPV) And Cervical Cancer Screening PCT PCT PCT/US2010/020499 Abandoned
NIAID E-285-2002-0-MX-20 Lutzomyia Longipalpis Polypeptides and Methods of Use MX DIV MX/a/2010/000185 Expired
NIAID E-172-2007-2-US-02 Aegyptin and Uses Thereof US National Stage 12/668,177 8383589 Issued PDF
NIAID E-335-2003-1-US-10 Mechanisms For Improving The Breadth Of The Immune Response To Diverse Strains And Clades Of HIV US CON 12/683,844 7947822 Abandoned PDF
NCI E-086-2010-0-US-01 Prostate Tumor-Associcated Dendritic Cell Induction of Tolerance and Suppressor Activity in Tumor... - US 61/293,098 Abandoned
NCI E-103-2007-0-US-03 Improved DNA Vaccination Protocol US National Stage 12/522,775 8586055 Issued PDF
NIA E-016-2009-0-US-02 Nucleic Acid Modules for Expression and Tagging of Membrane Proteins and Methods of Use US ORD 12/652,395 8501925 Abandoned PDF
NIDCD E-201-2007-2-US-01 Combination Of Treatments For More Efficient Novel Cancer Treatment Principle US CIP 12/667,687 8680129 Issued PDF
NCI E-137-2002-0-US-10 METHODS FOR TREATING CANCER IN HUMANS US DIV 12/651,858 Abandoned
NIAID E-204-2008-0-PCT-02 LJL143 Sand Fly Salivary Proteins As Novel Factor Xa Inhibitors and Methods Of Use PCT PCT PCT/US2009/069877 Abandoned
NIAID E-205-2008-0-PCT-02 Sand Fly Salivary Proteins (LJM04, LJM11, LJM26, LJL143, And LJMI9) With Anti-complement Activity And Methods of Their Use PCT PCT PCT/US2009/069874 Abandoned
NIEHS E-255-2007-0-US-05 Detecting And Controlling Abnormal Hematopoiesis US National Stage 12/667,287 Abandoned
NEI E-241-1999-0-US-07 Ocular Therapeutic Agent Delivery Devices And Methods For Making And Using Such Devices US DIV 12/647,980 Abandoned
NHLBI E-253-2009-0-US-01 Compisite Probes and Use Thereof in Super Resolution Methods US 61/290,282 Abandoned
NCI E-141-2008-0-JP-05 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof JP National Stage 2010-514839 Abandoned
NIA E-354-2004-0-US-08 Protomic Profiles Associated With Osteoarthritis And Aging US DIV 12/647,166 Abandoned
NIAID E-300-2009-2-US-01 Neutralizing Antibodies Against HIV-1 And Their Use US 61/290,135 Abandoned
NCI E-141-2008-0-NZ-06 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof NZ National Stage 582330 Issued
NICHD E-254-2009-0-US-01 Identification OfNovel Thermostable Y-Family Polymerases From Fungi. US 61/289,901 Abandoned
NCI E-154-2009-0-PCT-02 INHIBITORS OF MRE11, RAD50 AND/OR NBS1 PCT PCT PCT/US09/69171 Abandoned
NCI E-325-2008-0-PCT-02 Survivin Specific T Cell Receptor For Immunotherapy Of Cancer PCT PCT PCT/US2009/69248 Abandoned
NCI E-042-2006-0-US-14 Protective Complement Proteins and Age-related Macular Degeneration US CON 12/645,272 Abandoned
NIEHS E-334-2008-0-PCT-02 Artificial Splicing Factors With PUF Protein RNA-binding Domain And Splicing Effector Domains PCT PCT PCT/US2009/69041 Abandoned
NINDS E-160-2009-2-CA-03 Quinone Derivative 2,3-Dimethoxy-5-Methyl-6-(10-Hydroxydecyl)-1,4-Benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis CA National Stage 2760338 Abandoned
NINDS E-160-2009-2-CY-12 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis CY EP 09795720.3 Abandoned
NINDS E-160-2009-2-HR-21 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis HR EP 09795720.3 Abandoned
NINDS E-160-2009-2-CZ-13 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis CZ EP 09795720.3 Abandoned
NINDS E-160-2009-2-EE-16 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis EE EP 09795720.3 Abandoned
NINDS E-160-2009-2-DK-15 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis DK EP 09795720.3 Abandoned